FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808685989> ?p ?o ?g. }

• W2808685989 abstract "Osteosarcoma, the most common malignant bone tumor with recurring disease or lung metastases, has become one of the leading causes of death in humans. In the current study, we made an investigation on the anticancer effect of glaucocalyxin A, a bioactive ent-kauranoid diterpenoid isolated from Rabdosia japonica var., and unraveled the underlying mechanisms. Here, we found that Glaucocalyxin A inhibited the cell viability of numerous osteosarcoma cells. Our results showed that Glaucocalyxin A exerted the pro-apoptotic effect on human osteosarcoma cells, MG-63 and HOS cells. Glaucocalyxin A induced apoptosis by mitochondrial apoptotic pathway through several steps including increasing the Bax/Bcl-2 ratio, triggering the intracellular reactive oxygen species (ROS) generation, reducing mitochondrial membrane potential (MMP), and inducing cleavage of caspase-9 and caspase-3. We demonstrated that Glaucocalyxin A induced apoptosis via inhibiting Five-zinc finger Glis 1 (GLI1) activation by overexpression and knockdown of GLI1 in vitro. We also found that Glaucocalyxin A inhibited GLI1 activation via regulating phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) signaling pathway. We further confirmed our findings by using PI3K activator and inhibitor to verify the inhibitory effect of Glaucocalyxin A on PI3K/Akt/GLI1 pathway. Moreover, our in vivo study revealed that glaucocalyxin A possessed a remarkable antitumor effect with no toxicity in the xenograft model inoculated with HOS tumor through the same mechanisms as in vitro. In conclusion, our results suggested that Glaucocalyxin A induced apoptosis in osteosarcoma by inhibiting nuclear translocation of GLI1 via regulating PI3K/Akt signaling pathway. Thus, Glaucocalyxin A might be a potential candidate for human osteosarcoma in the future." @default.
• W2808685989 created "2018-06-21" @default.
• W2808685989 creator A5011078484 @default.
• W2808685989 creator A5026984704 @default.
• W2808685989 creator A5035315901 @default.
• W2808685989 creator A5043311357 @default.
• W2808685989 creator A5066934433 @default.
• W2808685989 creator A5070060968 @default.
• W2808685989 creator A5073501391 @default.
• W2808685989 creator A5075912868 @default.
• W2808685989 creator A5087199136 @default.
• W2808685989 date "2018-06-13" @default.
• W2808685989 modified "2023-10-14" @default.
• W2808685989 title "Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway" @default.
• W2808685989 cites W1120014072 @default.
• W2808685989 cites W1493106153 @default.
• W2808685989 cites W1496351322 @default.
• W2808685989 cites W1527009475 @default.
• W2808685989 cites W1660389086 @default.
• W2808685989 cites W1961187943 @default.
• W2808685989 cites W1992280242 @default.
• W2808685989 cites W1995392458 @default.
• W2808685989 cites W2002259918 @default.
• W2808685989 cites W2004630197 @default.
• W2808685989 cites W2009430421 @default.
• W2808685989 cites W2026816359 @default.
• W2808685989 cites W2028641592 @default.
• W2808685989 cites W2029431452 @default.
• W2808685989 cites W2030363360 @default.
• W2808685989 cites W2038974089 @default.
• W2808685989 cites W2041115282 @default.
• W2808685989 cites W2044965556 @default.
• W2808685989 cites W2046483653 @default.
• W2808685989 cites W2047757514 @default.
• W2808685989 cites W2048167482 @default.
• W2808685989 cites W2048851591 @default.
• W2808685989 cites W2051972832 @default.
• W2808685989 cites W2052853635 @default.
• W2808685989 cites W2054657634 @default.
• W2808685989 cites W2058594499 @default.
• W2808685989 cites W2060003051 @default.
• W2808685989 cites W2061497413 @default.
• W2808685989 cites W2063266633 @default.
• W2808685989 cites W2063879050 @default.
• W2808685989 cites W2075876263 @default.
• W2808685989 cites W2077842353 @default.
• W2808685989 cites W2082128755 @default.
• W2808685989 cites W2083169077 @default.
• W2808685989 cites W2088394753 @default.
• W2808685989 cites W2089179512 @default.
• W2808685989 cites W2090359076 @default.
• W2808685989 cites W2092718140 @default.
• W2808685989 cites W2107337105 @default.
• W2808685989 cites W2107394975 @default.
• W2808685989 cites W2120939161 @default.
• W2808685989 cites W2124014886 @default.
• W2808685989 cites W2127748864 @default.
• W2808685989 cites W2140350596 @default.
• W2808685989 cites W2144556646 @default.
• W2808685989 cites W2151907359 @default.
• W2808685989 cites W2151996381 @default.
• W2808685989 cites W2161641464 @default.
• W2808685989 cites W2170839629 @default.
• W2808685989 cites W2171424206 @default.
• W2808685989 cites W2178741632 @default.
• W2808685989 cites W2258928182 @default.
• W2808685989 cites W2515405003 @default.
• W2808685989 cites W2522521543 @default.
• W2808685989 cites W2556502410 @default.
• W2808685989 cites W2600296286 @default.
• W2808685989 cites W2601973198 @default.
• W2808685989 cites W2606366629 @default.
• W2808685989 cites W2757937798 @default.
• W2808685989 cites W4246742253 @default.
• W2808685989 cites W773076338 @default.
• W2808685989 doi "https://doi.org/10.1038/s41419-018-0684-9" @default.
• W2808685989 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5999605" @default.
• W2808685989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29899333" @default.
• W2808685989 hasPublicationYear "2018" @default.
• W2808685989 type Work @default.
• W2808685989 sameAs 2808685989 @default.
• W2808685989 citedByCount "32" @default.
• W2808685989 countsByYear W28086859892018 @default.
• W2808685989 countsByYear W28086859892019 @default.
• W2808685989 countsByYear W28086859892020 @default.
• W2808685989 countsByYear W28086859892021 @default.
• W2808685989 countsByYear W28086859892022 @default.
• W2808685989 countsByYear W28086859892023 @default.
• W2808685989 crossrefType "journal-article" @default.
• W2808685989 hasAuthorship W2808685989A5011078484 @default.
• W2808685989 hasAuthorship W2808685989A5026984704 @default.
• W2808685989 hasAuthorship W2808685989A5035315901 @default.
• W2808685989 hasAuthorship W2808685989A5043311357 @default.
• W2808685989 hasAuthorship W2808685989A5066934433 @default.
• W2808685989 hasAuthorship W2808685989A5070060968 @default.
• W2808685989 hasAuthorship W2808685989A5073501391 @default.
• W2808685989 hasAuthorship W2808685989A5075912868 @default.
• W2808685989 hasAuthorship W2808685989A5087199136 @default.
• W2808685989 hasBestOaLocation W28086859891 @default.
• W2808685989 hasConcept C153911025 @default.

• next